CSTL Sale Disclosure
Juvenal Tobin W · SEC Form 4 · Filed Oct 28, 2026
Sale
Calculated transaction value
$108.77K
Juvenal Tobin W Chief Commercial Officer
CSTL
Castle Biosciences
CSTL
Transaction date
Oct 26, 2026
Public filing date
Oct 28, 2026
Filing lag
Filed 2 days later
CSTL daily price context
Close on/before transaction
$33.3
Oct 26, 2026
First close after public filing
$38.51
Oct 29, 2026
Return after filing · so far
-15.55%
Through Nov 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 3,288 shares @ $33.08
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001628280-26-067887
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$108.77K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Castle Biosciences Inc CSTL Current | Sale | Oct 26, 2026 | $108.77K |